Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Hadaschik

Showing results (121-130 of 269) with videos related to

Pageof 27
Sort By:
Pathologie (Heidelberg, Germany)|April 19, 2024
[Rare tumors and tumor types of the urinary system in the 5th edition of the WHO classification 2022]Henning Reis, Hikmat Al-Ahmadie, Tibor Szarvas, et al.
The Journal of Sexual Medicine|June 15, 2019
Factors Associated with Low Sexual Desire in 45-Year-Old Men: Findings from the German Male Sex-StudyValentin H Meissner, Lukas Schroeter, Frank-Michael Köhn, et al.
European Urology Oncology|September 18, 2023
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysisTamás Fazekas, Ádám D Széles, Brigitta Teutsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020
PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center StudyManuel Weber, Claudia Kurek, Francesco Barbato, et al.
Molecular Cancer Research : MCR|January 14, 2010
Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cellsAmina Zoubeidi, Susan Ettinger, Eliana Beraldi, et al.
Sexual Medicine|January 15, 2019
Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex StudyJacqueline Hallanzy, Martina Kron, Veronika E Goethe, et al.
Cancers|October 28, 2023
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective RegistryChristoph Pöttgen, Christian Hoffmann, Thomas Gauler, et al.
The Journal of Pathology. Clinical Research|March 28, 2026
Molecular subtype concordance and metastatic patterns in muscle-invasive bladder cancerCsilla Olah, Dániel Juhász, Melinda Váradi, et al.
Journal of Cancer|April 4, 2017
Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German CentersStefanie Zschäbitz, Sonia Vallet, Boris Hadaschik, et al.
Urologia Internationalis|December 16, 2024
Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary CenterMulham Al-Nader, Ulrich Krafft, Christopher Darr, et al.
Pageof 27

Showing results (121-130 of 269) with videos related to

Sort By:
Pageof 27
Pathologie (Heidelberg, Germany)|April 19, 2024
[Rare tumors and tumor types of the urinary system in the 5th edition of the WHO classification 2022]Henning Reis, Hikmat Al-Ahmadie, Tibor Szarvas, et al.
The Journal of Sexual Medicine|June 15, 2019
Factors Associated with Low Sexual Desire in 45-Year-Old Men: Findings from the German Male Sex-StudyValentin H Meissner, Lukas Schroeter, Frank-Michael Köhn, et al.
European Urology Oncology|September 18, 2023
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysisTamás Fazekas, Ádám D Széles, Brigitta Teutsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020
PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center StudyManuel Weber, Claudia Kurek, Francesco Barbato, et al.
Molecular Cancer Research : MCR|January 14, 2010
Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cellsAmina Zoubeidi, Susan Ettinger, Eliana Beraldi, et al.
Sexual Medicine|January 15, 2019
Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex StudyJacqueline Hallanzy, Martina Kron, Veronika E Goethe, et al.
Cancers|October 28, 2023
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective RegistryChristoph Pöttgen, Christian Hoffmann, Thomas Gauler, et al.
The Journal of Pathology. Clinical Research|March 28, 2026
Molecular subtype concordance and metastatic patterns in muscle-invasive bladder cancerCsilla Olah, Dániel Juhász, Melinda Váradi, et al.
Journal of Cancer|April 4, 2017
Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German CentersStefanie Zschäbitz, Sonia Vallet, Boris Hadaschik, et al.
Urologia Internationalis|December 16, 2024
Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary CenterMulham Al-Nader, Ulrich Krafft, Christopher Darr, et al.
Pageof 27